Circulating sCD138 and Some Angiogenesis-Involved Cytokines Help to Anticipate the Disease Progression of Early-Stage <mml:math><mml:mi>B</mml:mi></mml:math>-Cell Chronic Lymphocytic Leukemia

<p>Syndecan-1 (CD138) is a transmembrane heparin sulfate proteoglycan expressed on distinct stages of differentiation of <mml:math><mml:mi>B</mml:mi></mml:math>-lymphoid cells. Its prognostic value in <mml:math><mml:mi>B</mml:mi></mml:math>-cell...

Full description

Saved in:
Bibliographic Details
Format: Article
Language:English
Published: Wiley 2006-01-01
Series:Mediators of Inflammation
Online Access:http://www.hindawi.com/GetArticle.aspx?doi=10.1155/MI/2006/42394
Tags: Add Tag
No Tags, Be the first to tag this record!